Skip to main content

Exact Sciences to Participate in March Investor Conferences

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

  • TD Cowen Health Care Conference, Boston

    Fireside chat on Monday, March 3, 2025 at 10:30 a.m. ET
  • Raymond James Institutional Investors Conference, Orlando

    Presentation on Tuesday, March 4, 2025 at 1:05 p.m. ET

The webcasts can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.97
+4.82 (2.40%)
AAPL  265.43
+1.55 (0.59%)
AMD  202.52
-0.56 (-0.28%)
BAC  53.33
+0.59 (1.12%)
GOOG  305.04
+2.22 (0.73%)
META  641.50
+2.22 (0.35%)
MSFT  401.42
+4.56 (1.15%)
NVDA  189.13
+4.16 (2.25%)
ORCL  157.18
+3.21 (2.08%)
TSLA  416.32
+5.69 (1.39%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.